tbl 6 pathology readings Flashcards
What is the viral genome of Hep A-E
Hepatitis A, C, E: ssRNA
Hepatitis B: partially dsDNA
Hepatitis D: circular defective ssRNA
What viral family is Hepatitis A from?
Hepatovirus, related to picornavirus
What viral family is Hepatitis B from?
Hepadnavirus
What viral family is Hepatitis C from?
Flaviviridae
What viral family is Hepatitis D from?
Subviral particle in Deltaviridae family
What viral family is Hepatitis E from?
Calcivirus
Route of transmission for Hepatitis A?
faecal oral (contaminated food or water)
Route of transmission for Hepatitis B?
Parenteral, sexual contact, perinatal
Route of transmission for Hepatitis C?
Parenteral; intranasal cocaine use is a risk factor
Route of transmission for Hepatitis D?
Parenteral
Route of transmission for Hepatitis E?
Fecal-oral
How to diagnose Hepatitis A?
Detection of serum IgM antibodies
How to diagnose Hepatitis B?
Detection of HBsAg or antibody to HBcAg; PCR for HBV DNA
How to diagnose Hepatitis C?
ELISA for antibody detection; PCR for HCV RNA
How to diagnose Hepatitis D?
Detection of IgM and IgG antibodies, HDV RNA in serum, or HDAg in liver biopsy
How to diagnose Hepatitis E?
Detection of serum IgM and IgG antibodies; PCR for HEV RNA
[HAV]
HAV usually is a benign self-limited infection that does not cause chronic hepatitis and rarely (in about 0.1% of cases) produces fulminant hepatitis. HAV has an incubation period of ___________. It is typically cleared by the host immune response, so it does not establish a carrier state. The infection occurs throughout the world and is endemic in countries with poor hygiene and sanitation.
Acute HAV tends to cause a ________________ and nonspecific symptoms such as fatigue and loss of appetite. Overall, HAV accounts for about 25% of clinically evident acute hepatitis worldwide.
HAV is a small, _____________ positive-strand RNA picornavirus that occupies its own genus, Hepatovirus . Ultrastructurally, HAV is an icosahedral capsid 27 nm in diameter. The receptor for HAV is HAVcr-1, a membrane glycoprotein that also may serve as a receptor for _______________. HAV is spread by ingestion of contaminated water and food and is shed in the stool for 2 to 3 weeks before and 1 week after the onset of jaundice. Thus, close personal contact with an infected individual or fecal-oral contamination accounts for most cases and explains outbreaks in institutional settings such as schools and nurseries, as well as water-borne epidemics in places where people live in overcrowded, unsanitary conditions. HAV can also be detected in serum and saliva of infected individuals.
In developed countries, sporadic infections may be contracted by the consumption of __________________ that have concentrated the virus from seawater contaminated with human sewage. Infected workers in the food industry are another source of outbreaks. HAV itself does not seem to be cytopathic. The cellular immune response, particularly that involving cytotoxic CD8+ T cells, plays a key role in HAV-mediated hepatocellular injury.
Because HAV viremia is transient, blood-borne transmission is very rare; therefore, donated blood is not specifically screened for this virus. ________________ appears in blood at the onset of symptoms and is a reliable marker of acute infection. Fecal shedding of the virus ends as the IgM titer rises. The IgM response usually declines in a few months followed by the appearance of IgG anti-HAV that persists for years, often conferring lifelong immunity. However, there are no routinely available tests for IgG anti-HAV; the presence of IgG anti-HAV is inferred from the difference between total and IgM anti-HAV. The HAV vaccine, available since 1992, is effective in preventing infection.
3-6 weeks;
febrile illness associated with jaundice;
nonenveloped;
Ebola virus;
IgM antibody against HAV;
raw or steamed shellfish
[HBV]
HBV is a member of __________________, a family of DNA viruses that cause hepatitis in multiple animal species. The HBV genome is a partially double-stranded, 3200-nucleotide, circular DNA with four open reading frames, which encode the following proteins:
- _______________ (HBcAg, hepatitis B core antigen) and a longer polypeptide with a precore and core region, designated HBeAg (hepatitis B e antigen). The precore region directs the secretion of the HBeAg polypeptide into blood, whereas HBcAg remains in hepatocytes, where it participates in the assembly of virions.
- Envelope glycoproteins (HBsAg, hepatitis B surface antigen). Infected hepatocytes synthesize and secrete massive quantities of _________________ (mainly small HBsAg).
- A polymerase (Pol) with both ___________ and ____________________, which enables genomic replication to occur through a unique DNA → RNA → DNA cycle via an intermediate RNA template. This unusual polymerase is the target of drugs used to treat hepatitis B infection (described later).
- ______________, which is required for virus replication and which may act as a transcriptional transactivator for viral genes and a wide variety of host genes. It has been implicated in the pathogenesis of HBV-associated liver cancer.
Occasionally, mutated strains of HBV emerge that do not produce HBeAg but are replication competent and express HBcAg. In such patients, the _________ may be low or undetectable despite the presence of serum HBV DNA. A second ominous development is the appearance of HBV mutants in vaccinated individuals that replicate in the presence of normally protective anti-HBs antibodies.
The host immune response is the main determinant of the outcome of the infection. Innate immune mechanisms protect the host during initial phases of the infection, and a strong response by virus-specific CD4+ and CD8+ interferon γ–producing cells is associated with the resolution of acute infection. HBV generally is not directly hepatotoxic, and most hepatocyte injury is caused by _________________
Patient age at the time of infection is the best predictor of chronicity. In general, the younger the age at the time of HBV infection, the higher the chance of chronic infection. Treatment of chronic hepatitis B with viral polymerase inhibitors and interferon can slow disease progression, reduce liver damage, and prevent liver cirrhosis or liver cancer but does not eliminate the infection. As a result, treatment sometimes fails due to emergence of viruses bearing mutations that lead to drug resistance.
Hepadnaviridae;
Nucleocapsid “core” protein;
noninfective envelope glycoproteins;
DNA polymerase activity ; reverse transcriptase activity;
HBx protein;
HBeAg;
CD8+ cytotoxic T cells attacking infected cells.
[Hepatitis C virus]
HCV is a major cause of liver disease, with approximately 170 million individuals affected worldwide. Approximately 4.1 million Americans (1.6% of the population) have chronic HCV infection. Notably, there has been a decrease in the annual incidence of infection from a mid-1980s peak of over 230,000 new infections per year to 30,000 new infections per year currently, due primarily to a reduction in transfusion-associated cases as a result of effective screening procedures. Until recently, the number of patients with chronic infection appeared likely to continue to increase, but new therapies (discussed later) are changing the outlook for the better.
According to data from the Centers for Disease Control and Prevention (CDC), the most common risk factors for HCV infection are as follows:
- ______________
- Multiple sex partners
- Having had surgery within the last 6 months
- Needle stick injury
- Multiple contacts with an HCV-infected individual
- Employment in the medical or dental field
Currently, transmission of HCV by blood transfusion is close to zero in the United States; the risk for acquiring HCV by _____________ is about six times higher than that for HIV (1.8 vs. 0.3%). For children, the major route of infection is ______________. Some patients have multiple risk factors, but one-third of individuals have no identifiable risk factors, an enduring mystery.
HCV, discovered in 1989, is a member of the _____________ family. Just as in the case of HIV, an understanding of viral replication and assembly has facilitated the development of highly effective anti-HCV drugs . HCV is a small, enveloped, single-stranded RNA virus with a 9600-base genome encoding a single polyprotein that is processed by several proteases into 10 functional proteins. Included among these viral proteins is a viral protease that is needed for complete processing of the polyprotein; ___________, a protein that is essential for assembly of HCV into mature virions; and a viral RNA polymerase that is necessary for replication of the viral genome. Because of the low fidelity of the HCV RNA polymerase, the viral genome is inherently unstable, giving rise to new genetic variants at a high pace. This has led to the appearance of six major HCV genotypes worldwide, each with one or more “subspecies.” Infections in most individuals are due to a virus of a single genotype, but new genetic variants are generated in the host as long as viral replication persists. As a result, each patient usually comes to be infected with a population of divergent but closely related HCV variants known as quasispecies.
Intravenous drug abuse;
needle stick;
vertical perinatal transmission from the mother;
Flaviviridae;
NS5A;
[Hepatitis C virus]
The incubation period for HCV hepatitis ranges from 4 to 26 weeks, with a mean of 9 weeks. In about 85% of individuals, the acute infection is asymptomatic and goes unrecognized. HCV RNA is detectable in blood for 1 to 3 weeks, coincident with elevations in __________ . In symptomatic acute HCV infection, anti-HCV antibodies are detected in only 50% to 70% of patients; in the remaining patients, the anti-HCV antibodies emerge after 3 to 6 weeks. The clinical course of acute HCV hepatitis is milder than that of HBV. It is not known why only a small minority of individuals is capable of clearing HCV infection.
Persistent infection and chronic hepatitis are the hallmarks of HCV infection, despite the generally asymptomatic nature of the acute illness. In contrast to HBV, chronic disease occurs in the majority of HCV-infected individuals (80%–90%), and cirrhosis eventually occurs in as many as one-third. The mechanisms leading to chronicity are not well understood, but it is clear that the virus uses multiple strategies to evade host anti-viral immunity. In addition to rapid generation of genetic variants, which may allow the virus to elude neutralizing antibodies, HCV encodes proteins that inhibit __________________- and interferon signaling in hepatocytes, activites that would otherwise allow hepatocytes to resist viral infection.
In chronic HCV infection, _____________ persists in 90% of patients despite the presence of neutralizing antibodies. Hence, testing for HCV RNA must be done to confirm the diagnosis of chronic HCV infection. A characteristic clinical feature of chronic HCV infection is ___________________ separated by periods of normal or near-normal enzyme levels. However, even HCV-infected patients with normal transaminases are at high risk for developing permanent liver damage, and anyone with detectable serum HCV RNA needs treatment and long-term medical follow-up.
Fortunately, recent years have seen dramatic improvements in treatment of HCV infection that stem from development of drugs that specifically target the viral protease, RNA polymerase, and NS5A protein, all of which are required for production of virus. Combination therapy with these drugs (a strategy akin to triple drug therapy for HIV) has proven to be remarkably effective. The goal of current treatment is to eradicate HCV RNA, which is defined by the ________________________________ and is associated with a high probability of cure. Currently, over 95% of HCV infections are curable, and this can be expected to improve further as new anti-viral drugs become available. The major downside of these advances is their very high cost; a curative course of drug therapy costs over $100,000, and it is estimated that treatment of HCV infections in the United States alone may generate expenses of over $50 billion over the next 5 years.
serum transaminases;
Toll-like receptor;
circulating HCV RNA;
episodic elevations in serum aminotransferases;
absence of detectable HCV RNA in the blood 6 months after treatment is stopped
Hepatitis D Virus (HDV)
Also called the delta agent, HDV is a unique RNA virus that is dependent for its life cycle on HBV. Infection with HDV arises in the following settings:
- Coinfection by HDV and HBV. The HBV must become established first to provide the HBsAg, which is necessary for production of complete HDV virions. Coinfection with HBV and HDV is associated with higher rates of ________________________, particularly in intravenous drug abusers, and higher rates of progression to chronic infection, which is often complicated by emergence of liver cancer.
- Superinfection of a chronic HBV carrier by HDV. The superinfection presents 30 to 50 days later as severe acute hepatitis in a previously unrecognized HBV carrier or as an exacerbation of preexisting chronic hepatitis B. Chronic HDV infection occurs in 80% to 90% of such patients. The superinfection may have two phases: an acute phase with ______________ and suppression of HBV with high ______________, followed by a chronic phase in which HDV replication ________, HBV replication _________, ALT levels ____________, and the disease progresses to cirrhosis and hepatocellular cancer.
HDV infection occurs worldwide and affects an estimated 15 million individuals (about 5% of the 300 million individuals infected by HBV). Its prevalence varies, being highest in the Amazon basin, Africa, the Middle East, and Southern Italy, and lowest in Southeast Asia and China. In most western countries, it is largely restricted to intravenous drug abusers and those who have had multiple blood transfusions.
HDV RNA is detectable in the blood and liver at the time of onset of acute symptomatic disease. IgM anti-HDV is a reliable indicator of recent HDV exposure, but is frequently short-lived. Acute coinfection by HDV and HBV is associated with the presence of IgM against __________________ (denoting new infection with hepatitis B). With chronic delta hepatitis arising from HDV superinfection, HBsAg is present in serum, and anti-HDV antibodies (IgG and IgM) persist for months or longer. Because of its dependency on HBV, HDV infection is prevented by vaccination against HBV.
severe acute hepatitis and fulminant liver failure;
active HDV replication; ALT levels;
decreases; increases; fluctuate;
HDAg and HBcAg
HEV is an enterically transmitted, water-borne infection that usually produces a self-limiting disease. The virus typically infects young to middle-aged adults. HEV is a zoonotic disease with animal reservoirs that include monkeys, cats, pigs, and dogs. Epidemics have been reported in Asia and the Indian subcontinent, sub-Saharan Africa, and Mexico, and sporadic cases are seen in Western nations, particularly where pig farming is common and in travelers returning from regions of high incidence. Of greater importance, HEV infection accounts for 30% to 60% of cases of sporadic acute hepatitis in India, exceeding the frequency of HAV. A characteristic feature of HEV infection is the high mortality rate among __________________, approaching 20%. In most cases, HEV is not associated with chronic liver disease or persistent viremia. The average incubation period following exposure is 4 to 5 weeks.
Discovered in 1983, HEV is an unenveloped, positive-stranded RNA virus in the Hepevirus genus. Virions are shed in stool during the acute illness. Before the onset of clinical illness, HEV RNA and HEV virions can be detected by _________________. The onset of rising serum aminotransferases, clinical illness, and elevated IgM anti-HEV titers are virtually simultaneous. Symptoms resolve in 2 to 4 weeks, during which time the IgM titers fall and IgG anti-HEV titers rise.
pregnant women;
PCR in stool and serum;